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Abstract
Background: Akt (PKB) is a serine threonine protein kinase downstream of the phosphoinositide 3-kinase (PI3K)
pathway. In mammals, Akt is ubiquitously expressed and is associated with regulation of cellular proliferation,
metabolism, cell growth and cell death. Akt has been widely studied for its central role in physiology and disease,
in particular cancer where it has become an attractive pharmacological target. However, the mechanisms by which
Akt signaling regulates stem cell behavior in the complexity of the whole body are poorly understood. Planarians
are flatworms with large populations of stem cells capable of dividing to support adult tissue renewal and
regeneration. The planarian ortholog Smed-Akt is molecularly conserved providing unique opportunities to analyze
the function of Akt during cellular turnover and repair of adult tissues.
Results: Our findings abrogating Smed-Akt with RNA-interference in the planarian Schmidtea mediterranea led to a
gradual decrease in stem cell (neoblasts) numbers. The reduced neoblast numbers largely affected the maintenance
of adult tissues including the nervous and excretory systems and ciliated structures in the ventral epithelia, which
impaired planarian locomotion. Downregulation of Smed-Akt function also resulted in an increase of cell death
throughout the animal. However, in response to amputation, levels of cell death were decreased and failed to
localize near the injury site. Interestingly, the neoblast mitotic response was increased around the amputation area
but the regenerative blastema failed to form.
Conclusions: We demonstrate Akt signaling is essential for organismal physiology and in late stages of the Akt
phenotype the reduction in neoblast numbers may impair regeneration in planarians. Functional disruption of
Smed-Akt alters the balance between cell proliferation and cell death leading to systemic impairment of adult
tissue renewal. Our results also reveal novel roles for Akt signaling during regeneration, specifically for the timely
localization of cell death near the injury site. Thus, Akt signaling regulates neoblast biology and mediates in the
distribution of injury-mediated cell death during tissue repair in planarians.
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Background
The protein kinase Akt also known as PKB, regulates
multiple cellular functions including proliferation,
survival, and growth during embryonic development
and adult tissue homeostasis [1–5]. In mammals, Akt
expression is widely distributed across the body and
includes three isoforms, Akt-1-3 (PKBα, ß, and δ, re-
spectively) [1–3]. Akt is evolutionary conserved in
both its molecular structure and function among verte-
brate and invertebrate organisms [4–7]. Across meta-
zoans, Akt signaling integrates local and systemic
information central to cellular and organismal physiology.
Akt regulates adult stem cell proliferation, migration
and apoptosis and its deregulation has been implicated in
the progression of cancer, diabetes, and aging [1–4, 8–10].
Conditional deletions and transgenic approaches have
revealed key aspects of Akt signaling in hematopoietic,
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epithelial, neural and other tissues [2, 3, 11–14]. Nonethe-
less, there is limited understanding of how Akt signaling
controls the response of stem cells during cellular
turnover and tissue injury in the complexity of the
whole organism. This paucity is likely due to the ubiqui-
tous nature of this signaling pathway and the difficulty of
analyzing stem cells in their natural environment during
physiological cell turnover and regeneration in conven-
tional animal models [15–17].
Thus, we sought to investigate Akt function during
cellular turnover and injury using the planarian flatworm
Schmidtea mediterranea. This organism is well known
for its stem cell-based regenerative capability. Planarians
contain an abundant and accessible population of
somatic adult stem cells called neoblasts [18–21]. The
neoblasts are the only dividing cells in planarians and
constantly proliferate to repair tissues and support
systemic cellular turnover [21]. Recently, we described
that the genome of S. mediterranea contains a single
Akt ortholog termed Smed-Akt, which affects cell division
and impairs planarian locomotion [22]. This study defined
the role of Smed-Akt in abnormal cell proliferation
triggered by the abrogation of the phosphatase PTEN,
an upstream component of the Akt signaling pathway,
which is highly mutated in human cancers.
Here we report on an extended RNA-interference
(RNAi) strategy that disrupts Smed-Akt in the whole or-
ganism, to analyze its function on the response of neo-
blasts during systemic cell turnover and tissue repair.
Our results show, Smed-Akt abrogation leads to a grad-
ual decline in the number of neoblasts, accompanied by
massive cell death that affects cellular turnover and
maintenance of adult tissues. We also found that im-
paired locomotion in the Smed-Akt phenotype is due to
the disruption of cilia maintenance in the ventral epithe-
lium. Intriguingly, large-scale tissue injury is capable of
reducing the high levels of Smed-Akt(RNAi)-induced
levels of cell death, while increasing neoblast proliferation
near the wound site however, animals failed to complete
the formation of the regenerative blastema. Thus, our re-
sults reveal novel roles for Akt signaling during systemic
cell turnover and large-scale regeneration of adult tissues.
Results
Smed-Akt is Required for Proper Neoblast Function
Our previous studies identified in the planarian
Schmidtea mediterranea genome a single Akt ortholog
(Smed-Akt) to the mammalian Akt2/PKB-ß [22].
Smed-Akt is widely expressed in neoblasts and differenti-
ated cells and functional downregulation with RNA-
interference [Smed-Akt(RNAi)] led to the reduction of
neoblast numbers and loss of planarian locomotion [22].
To test whether Akt signaling plays additional roles in the
regulation of cellular turnover and tissue regeneration in
the adult body, we designed an RNAi protocol consisting
of six dsRNA microinjections that effectively downregu-
lated (8.4 folds) Smed-Akt expression over the span of 30
days (Fig. 1a).
Neoblast division was visualized through whole-mount
immunostaining against the α–phosphorylated histone-3
(H3P) antibody, which labels cells in G2/M phase of the
cell cycle (observed as yellow dots in Fig. 1b). Animals
subjected to Smed-Akt(RNAi) initially displayed an im-
portant increase in neoblast division (~0.75 fold) 10 days
post RNAi initiation, which was followed by a gradual
decline in mitoses, reaching ~ five-fold decrease by day
30, when compared to control (Fig. 1b, c). Importantly,
all samples were processed either before or a few days
after injection to avoid the possibility of injury-induced
increase in mitotic activity. To further characterize the
effects of Akt downregulation on the cell cycle dynam-
ics, we evaluated the incorporation of the bromodeox-
yuridine analog (BrdU) every ten days for one month
(Fig. 1d). BrdU is incorporated during the S phase of the
cell cycle and remains in the cell through multiple rounds
of cell division, albeit at lower concentrations in each suc-
cessive cell generation. Control and Smed-Akt(RNAi) ani-
mals were exposed to a single BrdU pulse at different time
points after the first dsRNA injection (i.e. 10, 20, and
30 days) and after 12 h samples were processed as
previously described [23]. Consistent with the mitotic
counts, BrdU positive cells increased in the first 10
days after Smed-Akt(RNAi) and gradually decrease to
almost undetectable levels after one month of RNAi
treatment (Fig. 1d). We also found a consistent trend in
the expression of genes associated with cell cycle regula-
tion (i.e. cyclin A, cyclin B, CDK1, CDK2, and CDK4),
which showed general increase during the first 10 days
and dramatically decreases in the successive days, further
confirming our observations in mitotic activity and BrdU
labeling upon Smed-Akt(RNAi) (Fig. 1e). The early in-
crease in gene expression and proliferative cells upon
Smed-Akt downregulation implies that the phenotype
most likely starts before day 10. Our results suggest that
Smed-Akt is essential to maintain the appropriate number
of proliferating neoblast during tissue renewal in adult
planarians.
To assess whether the effects of Smed-Akt(RNAi) are
restricted to cell cycle events, we analyzed the expres-
sion of markers associated with neoblasts and the early
and late division progeny (e.g. smedwi-1, Prog-1, and
Agat-1, respectively). This analysis revealed a dramatic
decrease in the expression of markers associated with
neoblasts and their progeny (Fig. 2a). Interestingly, the
pattern of expression for smedwi-1 and Agat-1 were simi-
lar to that previous observed in cell cycle genes, while the
marker for the early neoblast progeny (prog-1) followed a
somewhat different pattern, characterized by a strong
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downregulation from the beginning of Smed-Akt(RNAi).
Whole mount fluorescent in situ hybridization (FISH)
with markers of neoblasts and the post-mitotic progeny
one month after Smed-Akt(RNAi) further confirmed the
quantitative PCR (qPCR) results and showed a generalized
reduction in gene expression throughout the body, after
Smed-Akt(RNAi) (Additional file 1).
Proliferative neoblasts are contained within the ir-
radiation sensitive X1 population and can be isolated
via flow cytometry cell sorting (FACS) [24]. Recently,
cells within the X1 population were classified into
two functionally distinct subclasses, the zeta- and sigma-
neoblasts [25]. FACS was used to isolate equal number of
X1 cells from both control and Smed-Akt(RNAi) animals
after one month of RNAi. We used a larger number of ex-
perimental animals to obtain comparable amount of
FACS-isolated cells between both groups. The total RNA
extracted was processed to evaluate levels of expression of
markers of the sigma and zeta populations (Fig. 2b).
Markers of the sigma neoblast subpopulations tend to
increase upon Smed-Akt(RNAi), while there little to
no change in the zeta subclass, suggesting the effect
of Smed-Akt(RNAi) is not homogeneously distributed
among the neoblasts. Thus, additional experiments
are required to further define the differences between
gene expression in the neoblast subclasses and to
understand these implications. Altogether, our results
indicate that Smed-Akt is essential for the appropriate
expression of neoblast and progeny markers and suggests
that a gradual depletion in the number of neoblasts takes
place after Smed-Akt(RNAi).
Smed-Akt is a Critical Regulator of Cell Death in Planarians
A fine balance between stem cell proliferation and
programmed cell death enables physiological cellular
turnover that supports maintenance and growth of adult
tissues [26]. Over a 40 days starvation period, animals sub-
jected to Smed-Akt(RNAi) exhibited a ~3 fold reduction in






























































































































































































































Fig. 1 Downregulation of Smed-Akt(RNAi) reduces neoblast proliferation. a The dsRNA microinjection schedule is depicted on top. A total
of 6 injections (arrows) were performed during a 30 day (black line) period. The RNAi efficiency of the dsRNA microinjections was tested
with quantitative PCR(qPCR) on days 10, 20 and 30 after the first dsRNA injection, showing significant down-regulation relative to control.
b Whole-mount immunostaining of control and Smed-AKT(RNAi) worms, using anti-phosphorylated histone H3 (H3P) antibody to label the
distribution of cell division at days 10, 20 and 30 after first dsRNA injection. Yellow dots represent mitotic cells. Scale bar 200μm. c H3P-signal
quantification, represents fold change of cell division (mitoses per mm2) relative to the control at days 10, 20 and 30 after Smed-AKT(RNAi). A significant
increase in cell division was observed 10 days post first injection, which dramatically diminishes by day 30. d Quantification of fold change in
bromodeoxyuridine (BrdU) positive cells relative to the control at days 10, 20 and 30 after first injection. e Relative levels of gene expression, fold
change, of cell cycle markers 10, 20 and 30 days after first Smed-AKT(RNAi) injection. All analyses were performed using two or more experimental
sets with 10 or more animals per experiment at various time points after first dsRNA injection. For qPCR analysis, gene expressions are
relative to the ubiquitously expressed clone H.55.12e. Graphs represent mean ± s.e.m. of three of more independent experiments. P values
*** < 0.005 and **** < 0.0001, were calculated by two way ANOVA
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surface area compared to the control group (0.23 ± 0.08 vs
0.72 ± 0.07 mm2, respectively) (Fig. 3a). These results
together with the reduction in neoblast proliferation sug-
gests that the Smed-Akt(RNAi) phenotype may be accom-
panied by increased levels of cell death, contributing to an
accelerated reduction in animal size over time, and death
by ~45 days after the first injection.
Akt function has been implicated in cellular pro-
survival mechanisms [14, 27–29]. Thus, we examined
possible roles of Smed-Akt as regulator of cell death in
planarians by analyzing levels of cell death after RNAi
treatment. First, spatial distribution of cell death in the
whole body was evaluated using the terminal deoxynu-
cleotidyl transferase dUTP nick end-labeling (TUNEL)
assay [30]. These experiments revealed that Smed-Akt
(RNAi) double the number of TUNEL positive cells, 15
days after the first dsRNA injection and it gradually in-
crease to about threefold by day 30 of the RNAi treatment
(Fig. 3b). Despite a slight increase in TUNEL positive cells
by day 10 of Smed-Akt(RNAi) (data not shown), the pre-
dominant increase in cell death was observed around day
15 after the first dsRNA injection. TUNEL positive cells
appeared indistinctively scattered along the planarian body
at all times, suggesting this is a generalized event, most
likely involving both neoblasts and differentiated cells
(Fig. 3c). Next, we performed flow cytometry analysis
using Annexin V and 7AAD staining [31, 32]. This experi-
ment confirmed the high levels of cell death induced by
Smed-Akt(RNAi) may involve apoptosis and necrosis
(Fig. 3d). The increased levels of cell death in Smed-Akt
(RNAi) together with the overall animal size reduction in-
dicates that Akt is an important regulator of cellular turn-
over. The mechanisms are not entirely clear however, it is
possible that the impairment in tissue renewal may result
from either (1) an initial reduction in neoblast numbers
that fail to support homeostasis or (2) generalized cell



















































































































































































Fig. 2 Akt regulates expression of neoblast and progeny markers. a Gene expression levels for markers of neoblasts (smedwi-1) and neoblast early
(Prog-1) and late (AGAT-1) progeny were evaluated with qPCR at days 10, 20 and 30 after first dsRNA injection and represented in fold change
relative to each sample's individual control. b Fold change in gene expression levels involving markers of neoblast subpopulations sigma (blue) and
zeta (red). The mRNA levels were measured in X1 sorted cells at day 30 after first injection was used to determine gene expression of Smed-AKT(RNAi)
animals. All values are relative to equal number (~20,000) of X1 cells sorted from control-water injected animals at 30 days. Gene expressions are all
relative to the internal control, the ubiquitously expressed clone H.55.12e. Graphs represent mean ± s.e.m. of triplicated samples of two or more
biological replicates with at least ten animals per experiment. P values ** < 0.001, *** < 0.0005 and **** < 0.0001, were calculated by two way ANOVA
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Smed-Akt Regulates the Maintenance of Differentiated
Tissues
A distinctive macroscopic feature of the Smed-Akt
(RNAi) phenotype is the impairment of locomotion ac-
companied by the elongation of the whole body, which
are initiated as early as day 15 and progress for over 35
days after the first dsRNA injection (Additional file 2).
Planarian gliding is mediated by synchronized cilia
movement on the ventral epithelial surface of the animal
[33]. Since locomotion is impaired in Smed-Akt(RNAi)
animals, we therefore evaluated the status of cilia
through the expression levels of genes specifically corre-
sponding to intraflagellar transport machinery and fla-
gellar beating (IFT88, IC2, LC1, LRRC50 and DNAHβ-1)
[34, 35]. First, we observed through qPCR, a dramatic
reduction in the expression of cilia markers required for
the structural and mechanical integrity of cilia [34, 36]
(Fig. 4a). The reduction in gene expression of cilia
markers is detected as early as 10 days after Smed-Akt
(RNAi) and their expression continues to reduce over
time. Second, whole-mount staining with anti-α-Ac-tubu-
lin antibody allowed us to visualize the integrity of ciliated
Fig. 3 The impairment of Akt leads to increased cell death in S. mediterranea. a The reduction in animal size over time was recorded as the
difference in surface area (whole animal) expressed in percentage. Surface area measurements were followed for over 40 days of starvation in
both the control and Smed-AKT (RNAi) animal groups. Graph represent the mean ± s.e.m of five independent time courses with ten or more
animals per experiment. b Quantification of TUNEL-positive nuclei reveals a gradual increase in cell death from day 15 (~2.5 fold) to 30 days
(~6 fold) post first injection relative to its individual control. Graph represent mean ± s.e.m of three biological replicates consisting of five or more
animals per experiment. P-value * <0.05 and **** <0.0001, by one way-ANOVA. c Whole-mount immunostaining labeling TUNEL-positive nuclei (cell
death) with control on the left and Smed-AKT(RNAi) days 15, 20 and 30 on the right. Each time point consisted of at least two biological replicates with
5 or more animals each. Scale bar 200μm. d Flow cytometry analysis of Annexin V and 7 AAD expression, reveals the frequency distribution between
living and dead cells. Annexin V-7 AAD quadrant indicates live cells (green circle). Annexin V + 7 AAD and Annexin V + 7 AAD+ indicates cells that are
in early and late stages of cell death, respectively (red circle). The numbers in each quadrant indicate the percentage of cells with that staining profile.
All experiments were independently repeated three times with at least ten animals each time
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structures in the ventral epithelia, including parts of the
excretory system (e.g. proximal tubules and flame cells in
protonephridia) [22, 33–37]. We noted that one month
after Smed-Akt(RNAi), the anti-α-Ac-tubulin antibody sig-
nal is nearly absent in the areas corresponding to ventral
cilia, while control animals showed dense coverage by cilia
(magenta signal in Fig. 4b). The confocal stacks, 30 days
after Smed-Akt(RNAi), showed a marked reduction of ven-
tral cilia, making the proximal tubules and flame cells of
the excretory system readily evident (Fig. 4b). Together,
the results obtained through gene and protein expression
demonstrates that Smed-Akt is required for the structural
integrity of cilia and its maintenance. Additionally, our
findings suggest that the impaired locomotion in the Akt
phenotype is most likely a consequence of inadequate cilia
density in the ventral epithelia.
We next sought to evaluate whether the Smed-Akt
(RNAi) effects are specific to the ventral epithelia or if
they extend to other tissues. The excretory system in pla-
narians consists of protonephridial tubules including both
ciliated and non-ciliated structures that could be labeled





























































































Fig. 4 Akt is required for the maintenance of cilia in the ventral epithelia. a Gene expression levels of cilia specific markers at days 10, 20 and 30
after Smed-AKT(RNAi) relative to the control. Analysis of markers corresponding to intraflagellar transport machinery (IFT88) and flagellar beating
(IC2, LC1, DNAHβ-1 and LRRC50) reveal a marked reduction of gene expression as early as day 10 and it is further reduced by day 30 after first
injection in Smed-AKT(RNAi) animals. Gene expressions are all relative to the internal control, the ubiquitously expressed clone H.55.12e. Graphs
represent mean ± s.e.m. of triplicated samples of two or more biological replicates with at least ten animals per experiment. Significance ****
<0.0001 is determined through two way-ANOVA. b Images show control (top) and Smed-Akt (RNAi) (bottom) at day 30 after first dsRNA injection.
Images represent depth-coded maximum projections of confocal z-sections in the posterior specific ventral cilia and proximal structures stained
with Ac-Tubulin antibody. Superficial structures were labeled in magenta and structures near the dorsal epithelial layer appear in orange (color
code scale on the left). Magnified images (on the right) display the effects of Smed-AKT(RNAi) on ciliated structures (cilia in ventral epithelia is
represented in magenta and sections of the protonephridia in green and blue). Box with dotted lines outline regions of cilia in ventral epithelia, notice
the scattered magenta signal in the experimental group. Confocal z-sections were taken on three or more animals of two independent experiments.
Depth-coded projections were obtained using ImageJ software. Scale bar 100μm
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gene, respectively [36–38]. Additional markers to each por-
tion of the protonephridial tubules were recently mapped
[36], thus providing better opportunities to analyze effects
on the excretory system. Specifically, we evaluated the
expression of solute carrier transporters (slc) family of
genes expressed along the proximal and distal tubules, and
the collecting ducts of the protonephridia [36]. We further
extended the analysis to include planarian homologs of
nephrocystins known to regulate excretory functions and
upon their downregulation, lead to cyst-like disease in S.
mediterranea [36]. The results provided evidence of a gen-
eralized reduction in gene expression throughout the pro-
tonephridial structures and the nephrocystin markers
(NPHP5, 6 and 8) (Fig. 5a, b). The striking reduction in
gene expression in the protonephridial structures is evident
as early as 10 days after Akt disruption. However, macro-
scopic signs of excretory system defects such as edema and
clearing of body pigmentation are evident in Smed-Akt
(RNAi) animals (30/30) during advanced stages of the














































































































































































































Fig. 5 Down-regulation of Akt leads to a delayed onset of a cystic phenotype. a Levels of expression of solute carrier (slc) genes expressed along
the planarian protonephridia tubules (proximal and distal) and collecting ducts. There is a striking reduction in expression of all slc genes evident
as early as day 10 and is sustained through day 30 after Smed-AKT(RNAi). Each individual sample was analyzed relative to its individual control.
b Expression levels of nephrocystin markers (NPHP5, 6 and 8) at different time points after RNAi. Levels of expression for each gene are relative
to individual controls. All NPHP genes showed markedly reduction in gene expression across 30 days after the first dsRNA injection. In all cases,
gene expressions are relative to the internal control, the ubiquitously expressed clone H.55.12e. Graphs represent mean ± s.e.m. of triplicated
samples of two biological replicates consisting of at least ten animals per experiment. Significance **** <0.0001 is determined through two way-ANOVA.
c Cystic phenotype is seen in Smed-AKT(RNAi) animals by day ≥30 after first dsRNA injection (N= 30/30). In the live image, seen on the left, the features of
a cystic phenotype (elongation of the head and bloating of the tail) are highlighted by red arrows. Confocal z-stack images on the right, control (top) and
Smed-AKT(RNAi) (bottom), highlight protonephridial clusters (dotted lines)using Ac-Tubulin staining in the posterior ventral surface at day 30. Protonephridial
clusters contain tubules (yellow arrows) and flame cells (green arrows). The number of flame cells per proximal unit are strongly reduced (**** P< 0.0001,
student t-test) in Smed-AKT(RNAi) animals 4.77 ± 0.72 vs 13.63 ± 0.55 in control. Flame cell counts were obtained from 5 or more animals, totaling N=30 or
more clusters analyzed per condition
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(Additional file 3A). Formation of the edema phenotype is
consistent with the markedly downregulation of nephro-
cystin genes, and structural alterations in the proximal
structures of the protonephridia (Fig. 5c). Particularly,
Smed-Akt(RNAi) lead to a generalized decrease in
both (13.63 ± 0.55 vs 4.77 ± 0.37) and proximal tubules per
protonephridial unit (protonephridial unit is outlined
in Fig. 5c), when compared to control. This structural
disruption is consistent with the manifestation of
edema in planarians [36–38], further validating the
reduced integrity of the excretory system during the
advanced stages of the Smed-Akt(RNAi) phenotype.
To determine whether Smed-Akt(RNAi) also affects
other organs within planarians, we set out to explore
gene and protein expression of markers in terminally
differentiated tissues [21, 23, 39–43]. Specifically, mRNA
levels of genes associated with the nervous and digestive
system, connective and muscle tissues. The results
from these experiments demonstrated that most of the
genes screened (i.e. 8/10) tend to gradually deplete after
Smed-Akt(RNAi), but at least two of the markers including
the choline acetyltransferase ChAT (neurons) and tropo-
myosin (muscle) followed a different pattern characterized
by an increase in expression one month after Akt down-
regulation (Fig. 6a). Staining with the monoclonal anti-
body Smed-6G10 (6G10) that labels different muscle
fibers in the planarian body [44], revealed the disruption
of the Akt signaling affects planarian musculature. Specif-
ically, we observed the disorganization of circular and di-
agonal muscle fibers and the absence of signal in some
areas, suggesting alterations in the normal tissue architec-
ture (arrows in head and pharynx, Fig. 6b). The structural
changes in musculature may also explain the incapability
to ingest food after 20 days of Akt-RNAi (data not shown)
but also the animal’s ability to slightly maneuver through
peristaltic muscle contractions [34]. ISH experiments also
confirmed the widespread reduction in expression of
markers of the excretory (Smed-CAVII-1), and the nervous
(Smed-PC2) system, further supporting the notion that
disruption of tissue integrity is not restricted to one tissue
in particular but rather a more generalized event after
downregulation of Akt function (Additional files 3B, and 4).
Future experiments are needed to determine whether
particular cell types are more susceptible to structural
alterations after Akt systemic inhibition. Nonetheless,
these results together demonstrate Smed-Akt is essential
for the maintenance of tissues in planarians.
Smed-Akt(RNAi) Leads to Regeneration Defects
Tissue amputation triggers well-coordinated waves of
apoptosis and cellular proliferation aimed at recreating
missing tissues and organs within the regenerative blas-
tema. The Smed-Akt phenotype is characterized by a re-
duction in neoblast numbers and increased cell death,
affecting the maintenance of differentiated tissues. Thus,
we assessed how an unbalance in cell death and prolifera-
tion affects large-scale injury-induced regeneration in S.
mediterranea. We performed planarian head decapitations
after 30 days post-RNAi initiation and followed macro-
scopic and microscopic responses in regenerative body
trunks (Fig. 7). One week after amputation control ani-
mals formed head blastemas with photoreceptor pigmen-
tation, whereas Smed-Akt(RNAi) animals only formed a
marginal blastema with limited eye pigmentation (Fig. 7a).
Further experiments with antibodies that recognize brain
structures and visual neurons (i.e. anti-SYNORF1, anti-
VC1), revealed Smed-Akt(RNAi) animals failed to regener-
ate brain and visual neuronal connections (Figs. 7b, c).
Likewise, animals with tail amputation also fail to regener-
ate during the advanced phenotype, suggesting that the re-
duced number of neoblasts may affect both anterior and
posterior regeneration in Smed-Akt(RNAi) animals (data
not shown). These results also imply that injury-mediated
cell differentiation is active despite the initial high levels of
cell death and low levels of cellular proliferation.
Previous studies in S. mediterranea have shown that
localized waves of cell death concentrate to the injury
site and a systemic spike of neoblast division take place
within the first six hours post-amputation [30, 43]. We
followed both cell death and the mitotic response post
amputation for seven days and observed cell death is
suppressed over time, whereas cell division is increased
in Smed-Akt(RNAi) animals when compared to the initial
time point (Figs. 7d-g). Moreover, cell death not only re-
duced in Smed-Akt(RNAi) animals but it also failed to
localize to the injury site as is expected in the first six hours
post-amputation (Fig. 7d, e and Additional file 4A, B). The
system wide cell death expected was also absent even after
more than 2 days of amputation (Additional file 5A-C). In-
stead, TUNEL positive cells were slightly accumulated to
the uninjured, opposite end of the regenerating trunk (n =
10/10). Intriguingly, amputation in the Smed-Akt(RNAi)
group elicited a system-wide increase in cell division that
peaked at six hours post-amputation and was sustained
during the first week post-amputation (Fig. 7f, g). Addition-
ally, the experimental group was incapable of produ-
cing a timely and localized mitotic response at the
injury site, as seen in the control animals 2 days post
amputation. However, Smed-Akt(RNAi) animals exhibited
a delayed localization of cell division (i.e. 4 days post am-
putation), which persisted through 7 days post amputation
(Additional file 6A-C). We propose Smed-Akt functions as
regulator of cell death and proliferation, during large-scale
tissue regeneration in planarians.
Discussion
Maintenance of adult tissues proceeds through a fine
balance between cell death and cell division. Our results
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implicate Smed-Akt as a critical regulator of cellular
turnover, adult tissue maintenance, and regeneration.
Disrupting Smed-Akt signaling affects the number of
proliferative neoblasts during cellular turnover and alters
integrity and function of differentiated tissues. Strikingly,
tissue injury is capable of altering patterns of cell death
and cell proliferation after Akt downregulation.
The Smed-Akt phenotype is characterized by an initial
increase in cell division that is followed by a gradual de-
pletion in the number of proliferative neoblasts. The na-
ture of the signals triggering cell proliferation in the first
10 days of the phenotype are not clear, but it might in-
volve a compensatory response to overcome deficiencies
in cellular turnover due to abnormalities in ciliogenesis
[45–48]. Interestingly, even at late stages of the Akt
phenotype some neoblasts continue dividing probably to
self-renew and/or to continue supporting tissue turnover
to some extent as animals subjected to Smed-Akt(RNAi)
survive for over one month. Two non-exclusive scenar-
ios may explain the presence of dividing neoblasts after
Smed-Akt(RNAi): (1) residual Akt expression after RNAi,
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Fig. 6 Smed-AKT(RNAi) leads to a generalized reduction in the expression of genes in differentiated tissues and alterations in muscle fibers. a
Gene expression analysis of differentiated tissue markers at days 10, 20 and 30 after first dsRNA injection. All measurements are relative to the
their respective control. Analysis of genes related to the differentiated tissues: intestinal (porcn-1 and MAT), photoreceptors (ovo and tyrosinase),
central nervous system (ChAT and pc2), and connective and muscle tissues (collagen and tropomyosin, respectively). Smed-AKT(RNAi) strongly reduce
the expression of most markers except for ChAT and tropomyosin that are elevated by day 30 after RNAi. Gene expressions are all relative to the
internal control, the ubiquitously expressed clone H.55.12e. Graphs represent mean ± s.e.m. of triplicated samples of two or more independent
experiments with at least ten animals per experiment. Significance (*P<0.05 and ****P<0.0001) was determined with two way-ANOVA. b Whole-mount
immunostaining of intact control and Smed-AKT(RNAi) planarians at >day 25 post RNAi initiation with SMED-6G10 (muscle tissue) antibody. SMED-6G10
antibody specifically labels the circular and diagonal muscle fibers throughout the animal. When compared to the control, Smed-AKT(RNAi) showed disarray
in the muscle fibers in both the head (top images) and pharyngeal (bottom images) muscular structures (arrowheads). The images are representative of an
experiment with five animals in one biological replicate. Scale bar 200 μm
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demonstrated that Smed-Akt expression is strongly
downregulated after RNAi, however, additional experi-
ments involving specific antibody against SMED-AKT pro-
tein may be needed to rule out whether AKT protein is
still present and active, and (2) intrinsic differences among
neoblast populations may confer survival properties to a
select group of stem cells when Akt is downregulated.
This possibility is supported by the differential expression
displayed by neoblast subclasses after Smed-Akt(RNAi)
(Fig. 2b). Recent progress to unravel the diversity of
neoblast sub-populations suggest planarian stem cells
are more complex than previously anticipated [25, 49].
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Fig. 7 Akt is required for tissue regeneration. a Live images of control and Smed-Akt (RNAi) head blastema formation seven days post amputation.
Dashed red line represents the amputation plane. Scale bar 100μm. b Immunostaining labeling the visual neurons (anti-VC-1 antibody) and (c)
central nervous system (anti-SYNORF1 antibody) seven days post amputation. Arrows highlight these structures in both the control and Smed-Akt
(RNAi) animals and red dotted lines represent the plane of amputation. Scale bar 100μm. d TUNEL-positive nuclei post amputation, represented in
fold change compared to the control. Note that cell death decrease over time, a four fold difference in Smed-Akt (RNAi). e Immunostaining of
TUNEL-positive nuclei of trunk fragments 0 and 6 h post amputation. Scale bar 200 μm. f Levels of H3P positive cells over time post amputation
in control and Smed-Akt (RNAi). The quantification was performed on the regenerating trunk fragment. g Representative images showing mitotic
activity (red dots) after head amputation at 0 and 6 h in trunk fragments. All images are representative of two or more biological replicates
consisting of five animals or more per experiment. Scale bar 200 μm. Graphs represent mean ± s.e.m. of two or more biological replicates and
P values *<0.01, **<0.001, ***<0.0005 and ****<0.0001 were obtained with Wilcoxon test or two way ANOVA
Peiris et al. BMC Developmental Biology  (2016) 16:7 Page 10 of 15
Therefore, we envision future experiments would evaluate
individual neoblast subpopulations to identify whether
some neoblast subtypes are more susceptible to Akt
downregulation [3, 9, 10, 50, 51].
The increased amount of cell death in Smed-Akt
(RNAi) suggests this is a rather generalized event involv-
ing both neoblasts and differentiated cells. Our findings
implicate decisions of cellular survival greatly depend on
Akt signaling, but future experiments are required to dis-
cern whether apoptosis and/or necrosis initially target
neoblasts. This possibility may, in fact, reduce the number
of neoblasts making them unable to efficiently support de-
mands of cellular turnover, leading to generic tissue de-
fects. We did not address the mechanism of cell death in
the Smed-Akt phenotype but since the mitochondrial
pathway of apoptosis is remarkably conserved in planar-
ians; it may serve, as in vertebrates, as the favored mech-
anism for Akt-mediated cell death [2, 13, 30, 31, 52, 53].
Studies in mammals show that not all tissues respond
homogeneously in response to Akt deficiency, while
some do not show measurable changes (e.g. bone marrow
and pancreas), others undergo apoptosis (e.g. testes and
thymus) [52]. A fine balance between stem cell prolifera-
tion and programmed cell death enables physiological cel-
lular turnover to support adult tissue maintenance. Tissue
renewal is seen to be altered in Smed-Akt(RNAi) animals,
most likely due to the increased levels of cell death, which
reduce the number of proliferating neoblasts. Our findings
indicate that Smed-Akt(RNAi) lead to a heterogeneous
gene expression response and mixed effects on the archi-
tecture of differentiated tissues. This differential sensitivity
to Smed-Akt deficiency is observed early with alteration of
cilia-mediated locomotion and the late onset of a cystic
phenotype defined by a malfunctioning excretory system.
The effects of abrogated Smed-Akt in differentiated tissues
may depend on tissue-specific turnover rates but more ex-
periments are needed to better understand the phenotype
at systemic level.
The mechanisms by which cilia is strongly reduced
after Smed-Akt(RNAi) is unclear but our findings indi-
cating severe downregulation in IFT88 may suggest, as
in other systems [45–47, 54, 55], that phosphorylated
Akt fail to localize to the cilium at the cilliary base lead-
ing to disruption of the apical cellular projections. An
intriguing finding of the Smed-Akt(RNAi) phenotype is
the disruption of ciliated structures within the epithe-
lium and excretory system (e.g. flame cells and proximal
tubules), which is being recently introduced as an alter-
native model for cystic kidney disease [36]. Our results
showed a significant reduction in gene expression correl-
ating to ciliated structures, protonephridia and nephro-
cystins within the first 10 days of RNAi initiation that
persisted to decrease by day 30. Interestingly, impaired
locomotion in Smed-Akt(RNAi) animals became slightly
evident by day 15 after RNAi treatment, which was exac-
erbated over time, and the delayed onset of the edema
phenotype that correlated with a dysfunctional excretory
system. Planarian studies have shown functional down-
regulation of genes correlating to ciliated structures and
nephrocystins led to a rapid edema phenotype by 9–15
days post RNAi treatment [36–38]. These results imply
that Akt activity may facilitate the assembly of ciliated
structures by regulating gene and protein expression re-
quired for maintenance of these structures (e.g. IFT88,
NPHPs and SCL family of genes). It is also possible that
during the initial part of the Akt phenotype, functional
protonephridial units balance electrolyte and carry on
waste excretion to compensate the reduction in the
number of flame cells and proximal tubules. However, as
the phenotype progresses it become unsustainable deriv-
ing in extensive damage, leading to the collapse of the ex-
cretory system. Further experiments will be required to
discriminate how Akt signaling regulates the delayed onset
of cyst-like formations. Nonetheless, these results are also
significant because Akt signaling and cilia are emerging as
possible therapeutic target in leukemia and polycystic
disease [56–59]. Altogether, these findings highlight the
convenience of the planarian model for analyzing Akt
signaling dysfunction in the whole adult organism.
Akt has been studied extensively in the context of cancer
and as a regulator of cellular functions, but its participation
in large-scale regeneration remains poorly understood.
Our findings reveal that Akt plays critical roles during
planarian regeneration. Specifically, disruption of Akt im-
pairs the process of blastema formation but does not pre-
vent the initial peaks of cell proliferation upon amputation.
In response to amputation, some cells migrate and differ-
entiate to form an incipient blastema, which is discontin-
ued probably due to the lack of timely localization of cell
death near the wounded area. The mechanisms by which
cell death regulates the process of regeneration still re-
mains poorly understood [60]. Nonetheless, the Akt
phenotype presents unique opportunities to address
whether a particular signaling pathway and/or cell type
that plays major role in guiding injury-induced apoptosis.
We propose that Akt signaling serves as mediator of local-
ized cell death events during planarian regeneration.
The intriguing finding that injury-induced repair sig-
nals in Smed-Akt(RNAi) is capable of reducing cell death
is exciting and it reveals a novel role for Akt in large-
scale tissue regeneration. Uninjured animals subjected to
Smed-Akt(RNAi) show high levels of cell death and re-
stricted neoblast division, but within a few hours after
amputation, levels of apoptosis dramatically reduce while
cellular proliferation increase in the absence of func-
tional Akt. While future experiments will be required to
investigate the mechanisms contributing to injury-
mediated cellular death, these results imply tissue
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damage and repair may alter cellular decisions imposed
by a dysfunctional Akt pathway.
Conclusions
Our results demonstrate that Akt forms part of an ancient
signaling pathway controlling cellular fate decisions in
members of the lophotrocozoans. Thus, we introduce S.
mediterranea as a valuable model system to dissect Akt
function in stem cell-based cellular turnover and repair of
adult tissues. The mechanisms controlling the molecular
cascade guiding large-scale tissue regeneration are poorly
understood however, our analysis identified that Akt is ne-
cessary for events related with cell death during regener-
ation. Future experiments are needed to address the
injury-mediated signals capable of reverting levels of cell
death and proliferation in the absence of Akt signaling.
Methods
Planarian Culture
The clonal lines of the Planarian strain, Schmidtea medi-
terranea CIW4 was used for all experimental procedures
and were cultured as previously described [61].
RNAi Experiments
The synthesis of dsRNA was carried out as previously
described in [62] and microinjection experiments were
carried out following the schedule in Fig. 1a. Following
this injection schedule, phenotype was accomplished by
25–30 days post first injection. All experiments were
conducted 5 days after last injection.
Fixation and Whole Mount Immunofluoresence
Animals were fixed using the Carnoys fixation protocol
[63] unless otherwise stated. Primary antibody concentra-
tions were used as follows: α -H3P 1:250 (Millipore Cat#
05-817R); α -VC1 1:10,000 (Kind gift of K. Watanabe);
anti-α-Ac-Tubulin 1:500 (Sigma, clone 6-11B-1), Smed-
6G10 1:1000; SYNORF1 1:100 (Developmental Studies
Hybridoma Bank). Secondary antibody concentrations
were: Alexa488 (1:400) goat anti-mouse (Invitrogen
Cat# 673781), goat-anti-mouse HRP IgG 1:1000 (Life
Technologies), and Alexa568 (1:800) goat anti-rabbit
(Invitrogen Cat# 11036).
BrdU Staining
Single staining of BrdU staining was performed as previ-
ously described [23, 64].
Flow Cytometry Analysis and Cell Sorting
Planarians were dissociated as previously described
[24, 32]. Brielfy, 1X106 cells from dissociated planaria
were stained with DNA marker Draq5 (eBioscience
Cat # 65-0880-96) at a 1:500 dilution in CMF media
for 30 min at RT in the dark. Incubation with calcein
(Invitrogen Cat # C3100MP) 1:500 diluted in CMF media
for 10 min at RT was sufficient to stain live cells. BD
FACSDiva™ software was used for initial gating and
samples were either analyzed using LSRII flow cytometer
(BD Biosciences) or sorted using ARIAII flow cytometer
(BD Biosciences). Apoptotic cells were identified with
Annexin V (Pacific Blue) and 7-AAD (PECy5) staining ac-
cording the manufacturer’s instructions (eBiosence) and
additional modifications found in our protocol [32]. Flow
cytometry analyses were performed with FlowJo software
(version 8). Further details on this protocol can be found
in our previous publication [63].
TUNEL Assay
Cell death was measured, using the TUNEL assay that
labels double stranded DNA breaks with fluorescent
tags. Further details on this protocol can be found else-
where [30]. Animals were mounted and fluorescent im-
ages were captured and evaluated with Nikon AZ-100
multizoom microscope and NIS Elements software.
Quantification of Cellular Events, Planarian Measurements
and Imaging Processing
Nikon AZ-100 multizoom microscope and NIS Elements
(Nikon) AR 3.2 software was used to record animal behav-
ior and digital images of planarian and/or cellular events
within the animal. Whole animal measurements were cal-
culated using the number of cellular events (eg. H3P or
TUNEL- positive foci) per millimeter square. Area meas-
urement of planarian size decreases was conducted by
using 6 or more independent experiment containing 20 or
more animals per experiment. Both the control and Smed-
AKT(RNAi) animals were photographed using the same
magnification and area measurements (per mm) were cal-
culated along the 40 day time course. All areas were aver-
aged across experiments. Average areas taken at the site of
amputation were confined to a consistent area with a
width of 161.05 pixels and a height of 146.939pixels. Fold
change representations were determined by dividing ex-
perimental/control conditions. Additional details can be
found as previously described [63]. Nikon Eclipse Ti con-
focal microscope and E Z-C1 software were used to obtain
Z-stack images using 20X objective. Z-stacks containing
20 sections at 2-1μm intervals were processed using Image
J (1.48v). For all images, Adobe Photoshop and Adobe Il-
lustrator were used to adjust color and brightness.
Quantitative RT-PCR
RNA extraction and quantitative real-time PCR (RT-PCR)
reactions were preformed as previously described [63].
RT-PCR from sorted cells was obtained by dissociating
>20 animals per condition to extract RNA and prepare
cDNA as described before [63]. Equal amount of cells
were sorted from both control and experimental
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conditions, which in some cases required extra animals in
experimental groups to achieve the desired target number
of cells. In all cases, gene expressions are relative to the
ubiquitously expressed clone H.55.12e [24, 63]. Gene ex-
pression corresponds to the mean of triplicated samples of
at least two independent experiments with pooled RNA
extraction of >20 animals each. Fold change represents
standardized expression levels of Smed-Akt(RNAi)/Con-
trol. Each RNAi time point had its own corresponding
control RNA extract.
Whole Mount In Situ Hybridization (WISH)
WISH and fluorescent in situ hybridization were per-
formed on animals fixed in 5% N-acteyl cistein (NAC)
solution. Riboprobes were synthesized using T3 and T7
polymerase and digoxigenin-labeled ribonucletide mix
with specific PCR templates as previously described
[24, 63]. Further details about WISH protocols are
found as previously described [65].
Statistical Analysis
All graphs are expressed as mean ± s.e.m. Statistical ana-
lyses were performed with GraphPad Prism software. P
value less than 0.05 were considered statistically significant.
Availability of Data and Materials
The datasets supporting the conclusions of this article
are included within the article and its Additional files 1,
2, 3, 4, 5 and 6.
Ethics approval and consent to participate
The study does not involve human data or vertebrate
animals.
Additional files
Additional file 1: Smed-Akt(RNAi) abrogates the expression of markers of
neoblast and their postmitotic progeny. Representative images of
fluorescent in situ hybridization of smedwi-1 (neoblast marker), Smed-Prog-1
(early neoblast progeny marker) and Smed-AGAT-1 (late division progeny
marker) reveals an important reduction upon Smed-Akt(RNAi). Animals were
fixed 30 days post first injection. Experiments were repeated at least twice
with ten animals per experiment. Scale bar 200μm. (PDF 433 kb)
Additional file 2: The Smed-Akt(RNAi) phenotype exhibits a progressive
inhibition of locomotion. (A-D) Videos of live planarian under (A) 15 day,
(B) 20 days, (C) 25 days and (D) 30 days after first dsRNA injection. As
time progresses, the phenotype exacerbates. All videos were taken under
the same brightfield magnification. (PDF 199 MB)
Additional file 3: Smed-Akt(RNAi) leads to down regulation of genes
expressed in the excretory system and cyst-like phenotype. (A) Representative
live images taken along the time course post Smed-Akt(RNAi). The control is
seen on the top and live images of days 15, 25 and 35 post RNAi initiation
show the progression of a cyst-like phenotype (30/30) (elongation of the head
and bloating of the tail). Notice at 15 days post RNAi treatment, the planarian
is thinned and stretched when compared to the control (50/50). (B)
Fluorescent in situ hybridization of Smed-CAVII-1 (excretory system). The signal
for Smed-CAVII-1 is less intense in experimental than in control, indicated with
arrows in the posterior part of the animals upon Smed-Akt (RNAi) 30 days after
first dsRNA injection. Experiments were repeated at least twice with ten
animals per experiment. Scale bar 200μm. (C) Fold change in Smed-CAVII-1
gene expression relative to the control over the course of 10, 20 and 30 days
post first dsRNA injection. Gene expressions are all relative to the internal
control, the ubiquitously expressed clone H.55.12e. Graphs represent mean ±
s.e.m. of triplicated samples of two biological replicates with at least ten
animals per experiment. Significance (*** < 0.0005 and **** < 0.0001)
was determined with one way-ANOVA. (PDF 544 kb)
Additional file 4: Smed-Akt(RNAi) reduces the expression of CNS marker.
(Left) Representative images of fluorescent in situ hybridization of Smed-PC2
(central nervous system) expression depicts a reduction (yellow arrows)
upon Smed-Akt(RNAi). Animals were fixed 30 days after first dsRNA injection.
Experiments consisted of two biological replicates with ten animals per
experiment. Scale bar 200μm. (Middle) Heat map depicting the intensity of
signal generated by Smed-PC2 expression. For intensity images and graph,
low levels of expression are seen in purple and high levels of intensity are
seen in red. Reduced Smed-PC2 expression is also indicated via yellow
arrows. (Right) The graph on the right represent the distribution of
intensities from the pictures in the middle featuring anterior to the posterior
region of the animal (control in orange and experimental in gray). The
intensity measurement was obtained from the center of the anterior to the
center of the posterior (white line in the middle) vertical line by using
Image J software. Scale bar 200μm. (PDF 357 kb)
Additional file 5: Smed-Akt(RNAi) animals fails to induce local and
system-wide cell death response during regeneration. (A) Quantification
of the TUNEL-positive nuclei at the site of amputation at various time
points in regeneration, the control (black) and the experimental group
(grey). (B) Heat map depicting the intensity of signal generated by
TUNEL-positive cells 6 h post amputation at the site of head regeneration
(red line depicts amputation plane). For intensity images and graph, low
levels of expression are seen in purple and high levels of intensity in
TUNEL-positive cells are seen in yellow/red. The graphs on the right
represent the distribution of these intensities from the anterior to the
posterior region of the amputation site (control in orange and experimental
in gray). The intensity measurement was obtained from the area covered by
the semi-transparent vertical line by using Image J software. Scale bar
100μm. (C) Immunostaining of TUNEL-positive nuclei of trunk fragments
for both the control and experimental group at 6 h (localized cell death
response), 2 days (system-wide cell death response) and 7 days (blastema
formation) post amputation. Arrows indicate cell death dynamics, proper
dynamics (control) and improper dynamics (Smed-Akt(RNAi)). Yellow brackets
denote the formation of the blastema and its relative size. Scale bar
200μm. All images are representative of two or more biological replicates
consisting of five animals or more per experiment. Graphs represent
mean ± s.e.m. of two or more biological replicates and P values
* < 0.01, ** < 0.001, *** < 0.0005 and **** < 0.0001 were obtained
with two way ANOVA. (PDF 391 kb)
Additional file 6: Delayed mitotic response upon amputation in
Smed-Akt(RNAi) animals. (A) Mitotic activity at the site of amputation at various
time points during regeneration, control (black) and Smed-Akt(RNAi) in grey. (B)
Heat map depicting the intensity of signal generated by H3P-positive cells 4
days post amputation at the site of head regeneration. For intensity images and
graph, low levels of expression are seen in purple and high levels of intensity in
H3P -positive cells are seen in red. The graphs on the right represent the
distribution of these intensities from the anterior to the posterior region of the
amputation site (control in orange and experimental in gray). The intensity
measurement was obtained from the area covered by the semi-transparent
vertical line by using Image J software. Scale bar 100μm. (C) Whole-mount
immunostaining of H3P-positive cells on trunk fragments for both the control
and experimental group from 0 to 6 h (system-wide mitotic response), 2 to 4
days (localized mitotic response) and 7 days (blastema formation) post
amputation. Arrows indicate cell proliferation dynamics during regeneration,
proper dynamics (control) and improper dynamics (Smed-Akt(RNAi). Yellow
brackets denote the formation of the blastema and its size. Notice, at 4 and 7
days, mitotic activity is localized to the site of amputation. Scale bar 200μm. All
images are representative of two or more biological replicates consisting of five
animals or more per experiment. Graphs represent mean± s.e.m. of two or
more biological replicates and P values * < 0.01, ** < 0.001, *** < 0.0005 and
**** < 0.0001 were obtained with two way ANOVA. (PDF 282 kb)
Peiris et al. BMC Developmental Biology  (2016) 16:7 Page 13 of 15
Abbreviations
RNAi: RNA-interference; dsRNA: Double-stranded RNA; PI3K: Phosphoinositide
3-kinase; Smed-Akt: The planarian Akt ortholog; PTEN: Phosphatase and Tensin
homolog; BrdU: Bromodeoxyuridine analog; CDK1-4: Cyclin-Dependent
Kinase 1–4; Prog-1: Early division progeny −1; Agat-1: L-arginine:glycine
amidinotransferase marker of the neoblast late division progeny;
FACS: Fluorescence-activated cell sorting; anti-α-Ac-tubulin: antibody
against α-acetylated tubulin; TUNEL: Terminal deoxynucleotidyl transferase
dUTP nick end labeling; ChAT: Choline acetyltransferase; SYNORF1: Immunogen
sequence against synapsin-1; VC1: Visual cells −1; PC2: Prohormone
convertase-2; qPCR: Quantitative polymerase chain reaction; H3P: Phospho-
Histone H3 (Ser10) Antibody; WISH: Whole-mount in situ hybridization;
s.e.m.: Standard error of the mean.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
THP, DR, PGB, and NJO performed the research and analyzed data. N.J.O.
conceived the study, and participated in its design and coordination, and
wrote the final manuscript with PGB. All authors read and approved the
final manuscript.
Acknowledgments
We thank Edelweiss Pfister, Elyse Ozamoto, and Frank Weckerle for technical
assistance, members of the Oviedo lab, and Dr. Katrina Hoyer for comments
on the manuscript. We thank Dr. K. Watanabe for VC-1 antibody. The Smed-6G10
and SYNORF antibodies developed by Dr. R. Zayas at SDSU and Dr. E. Buchner at
the ICNUW were obtained from the Developmental Studies Hybrydoma Bank,
created by the NICHD of the NIH and maintained at the University of Iowa,
Department of Biology.
Funding
We acknowledge support from UC Merced, UC Cancer Research
Coordinating Committee, Health Sciences Research Institute at UCM, and
awards from Jane Vilas and the Hellman Fellows Fund. The NCI and NIGMS
of the National Institute of Health supported this research, awards CA176114
and GM109372 to NJO.
Author details
1Department of Molecular and Cell Biology, School of Natural Sciences,
University of California, 5200 North Lake Road, Merced, CA 95343, USA.
2Quantitative and Systems Biology Graduate Program, University of California,
Merced, CA 95343, USA. 3Health Sciences Research Institute, University of
California, Merced, CA 95343, USA.
Received: 23 September 2015 Accepted: 24 March 2016
References
1. Liao Y, Hung MC. Physiological regulation of Akt activity and stability. Am J
Trans Res. 2010;2(1):19–42.
2. Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W, Donowitz
M, Nagata E, Snyder SH. Akt as a mediator of cell death. Proc Natl Acad Sci
U S A. 2003;100(20):11712–7.
3. Hanada M, Feng J, Hemmings BA. Structure, regulation and function of PKB/
AKT–a major therapeutic target. Biochim Biophys Acta. 2004;1697(1–2):3–16.
4. Chuang CL, Lu YN, Wang HC, Chang HY. Genetic dissection reveals that
Akt is the critical kinase downstream of LRRK2 to phosphorylate and
inhibit FOXO1, and promotes neuron survival. Human Mol Genet.
2014;23(21):5649–58.
5. Kandel ES, Hay N. The regulation and activities of the multifunctional
serine/threonine kinase Akt/PKB. Exp Cell Res. 1999;253(1):210–29.
6. Gao X, Neufeld TP, Pan D. Drosophila PTEN regulates cell growth and
proliferation through PI3K-dependent and -independent pathways. Dev Biol.
2000;221(2):404–18.
7. Goberdhan DC, Paricio N, Goodman EC, Mlodzik M, Wilson C. Drosophila
tumor suppressor PTEN controls cell size and number by antagonizing the
Chico/PI3-kinase signaling pathway. Gene Dev. 1999;13(24):3244–58.
8. Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein
kinase B/Akt. FEBS letters. 2003;546(1):108–12.
9. Segrelles C, Garcia-Escudero R, Garin MI, Aranda JF, Hernandez P, Ariza JM,
Santos M, Paramio JM, Lorz C. Akt signaling leads to stem cell activation and
promotes tumor development in epidermis. Stem cells. 2014;32(7):1917–28.
10. Woodgett JR. Recent advances in the protein kinase B signaling pathway.
Curr Opin Cell Biol. 2005;17(2):150–7.
11. Bhatt AP, Damania B. AKTivation of PI3K/AKT/mTOR signaling pathway by
KSHV. Front Immunol. 2012;3:401.
12. Chen YL, Law PY, Loh HH. Inhibition of akt/protein kinase B signaling by
naltrindole in small cell lung cancer cells. Cancer Res. 2004;64(23):8723–30.
13. Fan QW, Cheng C, Hackett C, Feldman M, Houseman BT, Nicolaides T, Haas-Kogan
D, James CD, Oakes SA, Debnath J et al. Akt and autophagy cooperate to promote
survival of drug-resistant glioma. Sci Signal. 2010;3(147):ra81.
14. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the
mitochondria: AKTing on apoptosis. Cell Signal. 2008;20(1):21–30.
15. Tanaka EM, Reddien PW. The cellular basis for animal regeneration.
Developmental cell. 2011;21(1):172–85.
16. Sanchez Alvarado A, Tsonis PA. Bridging the regeneration gap: genetic
insights from diverse animal models. Nat Rev Genet. 2006;7(11):873–84.
17. Poss KD. Advances in understanding tissue regenerative capacity and
mechanisms in animals. Nat Rev Genet. 2010;11(10):710–22.
18. Aboobaker AA. Planarian stem cells: a simple paradigm for regeneration.
Trends Cell Biol. 2011;21(5):304–11.
19. Reddien PW. Specialized progenitors and regeneration. Development.
2013;140(5):951–7.
20. Rink JC. Stem cell systems and regeneration in planaria. Dev Gene Evol.
2013;223(1–2):67–84.
21. Wagner DE, Wang IE, Reddien PW. Clonogenic neoblasts are pluripotent
adult stem cells that underlie planarian regeneration. Science.
2011;332(6031):811–6.
22. Oviedo NJ, Pearson BJ, Levin M, Sánchez Alvarado A. Planarian PTEN
homologs regulate stem cells and regeneration through TOR signaling. Dis
Model Mech. 2008;1(2–3):131–43.
23. Cowles MW, Brown DD, Nisperos SV, Stanley BN, Pearson BJ, Zayas RM.
Genome-wide analysis of the bHLH gene family in planarians identifies
factors required for adult neurogenesis and neuronal regeneration.
Development. 2013;140(23):4691–702.
24. Reddien PW, Oviedo NJ, Jennings JR, Jenkin JC, Sanchez Alvarado A.
SMEDWI-2 is a PIWI-like protein that regulates planarian stem cells. Science.
2005;310(5752):1327–30.
25. van Wolfswinkel JC, Wagner DE, Reddien PW. Single-cell analysis reveals
functionally distinct classes within the planarian stem cell compartment.
Cell stem cell. 2014;15(3):326–39.
26. Pellettieri J, Sanchez Alvarado A. Cell turnover and adult tissue homeostasis:
from humans to planarians. Annu Rev Genet. 2007;41:83–105.
27. Benbrook DM, Masamha CP. The pro-survival function of Akt kinase can be
overridden or altered to contribute to induction of apoptosis. Curr Cancer
Drug Targets. 2011;11(5):586–99.
28. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell
death. Pharmacol Ther. 2001;92(1):57–70.
29. Rane MJ, Klein JB. Regulation of neutrophil apoptosis by modulation of
PKB/Akt activation. Front Biosci. 2009;14:2400–12.
30. Pellettieri J, Fitzgerald P, Watanabe S, Mancuso J, Green DR, Sanchez
Alvarado A. Cell death and tissue remodeling in planarian regeneration. Dev
Biol. 2010;338(1):76–85.
31. Bender CE, Fitzgerald P, Tait SW, Llambi F, McStay GP, Tupper DO, Pellettieri
J, Sanchez Alvarado A, Salvesen GS, Green DR. Mitochondrial pathway of
apoptosis is ancestral in metazoans. Proc Natl Acad Sci USA.
2012;109(13):4904–9.
32. Peiris TH, Garcia-Ojeda ME, Oviedo NJ: Alternative flow cytometry strategies to
analyze stem cells and cell death in planarians. Regeneration 2016, In press.
33. Rompolas P, Azimzadeh J, Marshall WF, King SM. Analysis of ciliary assembly
and function in planaria. Meth Enzymol. 2013;525:245–64.
34. Rompolas P, Patel-King RS, King SM. An outer arm Dynein conformational
switch is required for metachronal synchrony of motile cilia in planaria. Mol
Biol Cell. 2010;21(21):3669–79.
35. Sanchez Alvarado A, Newmark PA. Double-stranded RNA specifically
disrupts gene expression during planarian regeneration. Proc Natl Acad Sci
U S A. 1999;96(9):5049–54.
36. Thi-Kim Vu H, Rink JC, McKinney SA, McClain M, Lakshmanaperumal N,
Alexander R, Sanchez Alvarado A. Stem cells and fluid flow drive cyst
formation in an invertebrate excretory organ. eLife. 2015;4.
Peiris et al. BMC Developmental Biology  (2016) 16:7 Page 14 of 15
37. Rink JC, Vu HT, Sanchez Alvarado A. The maintenance and regeneration of the
planarian excretory system are regulated by EGFR signaling. Development.
2011;138(17):3769–80.
38. Scimone ML, Srivastava M, Bell GW, Reddien PW. A regulatory program
for excretory system regeneration in planarians. Development.
2011;138(20):4387–98.
39. Lapan SW, Reddien PW. Transcriptome analysis of the planarian eye
identifies ovo as a specific regulator of eye regeneration. Cell reports.
2012;2(2):294–307.
40. Witchley JN, Mayer M, Wagner DE, Owen JH, Reddien PW. Muscle cells
provide instructions for planarian regeneration. Cell reports. 2013;4(4):633–41.
41. Gurley KA, Rink JC, Sanchez Alvarado A. Beta-catenin defines head versus
tail identity during planarian regeneration and homeostasis. Science.
2008;319(5861):323–7.
42. Lapan SW, Reddien PW. dlx and sp6-9 Control optic cup regeneration in a
prototypic eye. PLoS genetics. 2011;7(8), e1002226.
43. Wenemoser D, Reddien PW. Planarian regeneration involves distinct stem
cell responses to wounds and tissue absence. Dev Biol. 2010;344(2):979–91.
44. Ross KG, Omuro KC, Taylor MR, Munday RK, Hubert A, King RS, Zayas RM.
Novel monoclonal antibodies to study tissue regeneration in planarians.
BMC Dev Biol. 2015;15:2.
45. Clement DL, Mally S, Stock C, Lethan M, Satir P, Schwab A, Pedersen SF,
Christensen ST. PDGFRalpha signaling in the primary cilium regulates
NHE1-dependent fibroblast migration via coordinated differential
activity of MEK1/2-ERK1/2-p90RSK and AKT signaling pathways. J Cell
Sci. 2013;126(Pt 4):953–65.
46. Higginbotham H, Guo J, Yokota Y, Umberger NL, Su CY, Li J, Verma N, Hirt J,
Ghukasyan V, Caspary T, et al. Arl13b-regulated cilia activities are essential
for polarized radial glial scaffold formation. Nat Neurosci. 2013;16(8):1000–7.
47. Christensen ST, Clement CA, Satir P, Pedersen LB. Primary cilia and
coordination of receptor tyrosine kinase (RTK) signalling. J Pathol. 2012;
226(2):172–84.
48. Jacoby M, Cox JJ, Gayral S, Hampshire DJ, Ayub M, Blockmans M, Pernot E,
Kisseleva MV, Compere P, Schiffmann SN, et al. INPP5E mutations cause
primary cilium signaling defects, ciliary instability and ciliopathies in human
and mouse. Na Genet. 2009;41(9):1027–31.
49. Scimone ML, Kravarik KM, Lapan SW, Reddien PW. Neoblast specialization in
regeneration of the planarian Schmidtea mediterranea. Stem cell reports.
2014;3(2):339–52.
50. Bernards R. A missing link in genotype-directed cancer therapy. Cell.
2012;151(3):465–8.
51. Pal SK, Reckamp K, Yu H, Figlin RA. Akt inhibitors in clinical development for
the treatment of cancer. Expet Opin Investig Drugs. 2010;19(11):1355–66.
52. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I,
Weng W, Suzuki R, Tobe K, et al. Growth retardation and increased
apoptosis in mice with homozygous disruption of the Akt1 gene. Gene
Dev. 2001;15(17):2203–8.
53. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM,
Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2
expression through cAMP-response element-binding protein. J Biol
Chem. 2000;275(15):10761–6.
54. Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P,
Christensen ST. PDGFRalphaalpha signaling is regulated through the
primary cilium in fibroblasts. Curr Biol. 2005;15(20):1861–6.
55. Zhu D, Shi S, Wang H, Liao K. Growth arrest induces primary-cilium
formation and sensitizes IGF-1-receptor signaling during differentiation
induction of 3T3-L1 preadipocytes. J Cell Sci. 2009;122(Pt 15):2760–8.
56. Boehlke C, Kotsis F, Patel V, Braeg S, Voelker H, Bredt S, Beyer T, Janusch H,
Hamann C, Godel M, et al. Primary cilia regulate mTORC1 activity and cell
size through Lkb1. Nat Cell Biol. 2010;12(11):1115–22.
57. Boletta A. Emerging evidence of a link between the polycystins and the
mTOR pathways. Pathogenetics. 2009;2(1):6.
58. Dere R, Wilson PD, Sandford RN, Walker CL. Carboxy terminal tail of polycystin-
1 regulates localization of TSC2 to repress mTOR. PLoS One. 2010;5(2), e9239.
59. Fischer DC, Jacoby U, Pape L, Ward CJ, Kuwertz-Broeking E, Renken C,
Nizze H, Querfeld U, Rudolph B, Mueller-Wiefel DE, et al. Activation of the
AKT/mTOR pathway in autosomal recessive polycystic kidney disease
(ARPKD). Nephrol Dial Transplant. 2009;24(6):1819–27.
60. Vriz S, Reiter S, Galliot B. Cell death: a program to regenerate. Curr Top Dev
Biol. 2014;108:121–51.
61. Oviedo NJ, Levin M. smedinx-11 is a planarian stem cell gap junction
gene required for regeneration and homeostasis. Development.
2007;134:3121–31.
62. Oviedo NJ, Nicolas C, Adams DS, Levin M. Gene knockdown in planarians
using RNAi interference. Cold Spring Harb Protocols. 2008;3(10):902–6.
63. Peiris TH, Weckerle F, Ozamoto E, Ramirez D, Davidian D, Garcia-Ojeda ME,
Oviedo NJ. TOR signaling regulates planarian stem cells and controls
localized and organismal growth. J Cell Sci. 2012;125(Pt 7):1657–65.
64. Newmark PA, Sanchez Alvarado A. Bromodeoxyuridine specifically labels the
regenerative stem cells of planarians. Dev Biol. 2000;220(2):142–53.
65. Pearson BJ, Eisenhoffer GT, Gurley KA, Rink JC, Miller DE, Sanchez Alvarado
A. Formaldehyde-based whole-mount in situ hybridization method for
planarians. Dev Dyn. 2009;238(2):443–50.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Peiris et al. BMC Developmental Biology  (2016) 16:7 Page 15 of 15
